Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+184.3%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+184.3%/yr
vs -19.0%/yr prior
Acceleration
+203.3pp
Accelerating
Percentile
P97
Near historical high
vs 3Y Ago
23x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 55.39% |
| Q2 2025 | 27.53% |
| Q1 2025 | 21.38% |
| Q4 2024 | -30.85% |
| Q3 2024 | -10.30% |
| Q2 2024 | -21.08% |
| Q1 2024 | -5.56% |
| Q4 2023 | -10.34% |
| Q3 2023 | 10.49% |
| Q2 2023 | 0.72% |
| Q1 2023 | 16.12% |
| Q4 2022 | -1.74% |
| Q3 2022 | 2.41% |
| Q2 2022 | -7.97% |
| Q1 2022 | -9.15% |
| Q4 2021 | 4.08% |
| Q3 2021 | -14.91% |
| Q2 2021 | -31.80% |
| Q1 2021 | -23.96% |
| Q4 2020 | 20.46% |
| Q3 2020 | -3.86% |
| Q2 2020 | -23.68% |
| Q1 2020 | 66.71% |
| Q4 2019 | -9.17% |
| Q3 2019 | -17.84% |
| Q2 2019 | 4.78% |
| Q1 2019 | -60.96% |
| Q4 2018 | -13.40% |
| Q3 2018 | 26.28% |
| Q2 2018 | -4.52% |
| Q1 2018 | 13.58% |
| Q4 2017 | 8.96% |
| Q3 2017 | 48.49% |
| Q2 2017 | -22.09% |
| Q1 2017 | 34.22% |
| Q4 2016 | -17.38% |
| Q3 2016 | -3.89% |
| Q2 2016 | 14.66% |
| Q1 2016 | -5.62% |
| Q4 2015 | -14.95% |